Eris Pharmaceuticals has
announced a license agreement
with Swiss firm Applied Pharma
Research for the distribution of the
Halykoo baby health product range
in Australia and New Zealand.
The pact will see Eris enter the
paediatric market, with Halykoo
developed by APR to match specific
formulations with the unique ages
and stages of children’s growth
along with specially created
delivery systems - see halykoo.com.The above article was sent to subscribers in Pharmacy Daily's issue from 04 Dec 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 Dec 15
RESPONDING to the findings from the Royal Commission into Aged Care Quality and Safety, a recent government initiative aims to improve medication management in residential aged care facilities by introducing on-site pharmacists.
RESEARCHERS at Charles Darwin University (CDU) are advancing a novel drug delivery system that could potentially eliminate the need for injections to treat various chronic diseases.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.